190 related articles for article (PubMed ID: 22006120)
21. Environmental risk factors differ between rheumatoid arthritis with and without auto-antibodies against cyclic citrullinated peptides.
Pedersen M; Jacobsen S; Klarlund M; Pedersen BV; Wiik A; Wohlfahrt J; Frisch M
Arthritis Res Ther; 2006; 8(4):R133. PubMed ID: 16872514
[TBL] [Abstract][Full Text] [Related]
22. Clinical and serological analysis of patients with positive anticyclic citrullinated Peptide antibodies referred through a Rheumatology Central Triage System.
Martin L; Steber WA; Lupton TL; Mahler M; Fitch CM; McMillan JD; Schmidt DR; Fritzler MJ
J Rheumatol; 2015 May; 42(5):771-7. PubMed ID: 25641884
[TBL] [Abstract][Full Text] [Related]
23. Quantitative heritability of anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis.
van der Woude D; Houwing-Duistermaat JJ; Toes RE; Huizinga TW; Thomson W; Worthington J; van der Helm-van Mil AH; de Vries RR
Arthritis Rheum; 2009 Apr; 60(4):916-23. PubMed ID: 19333951
[TBL] [Abstract][Full Text] [Related]
24. Recognizing rheumatoid arthritis: oncoprotein survivin opens new possibilities: a population-based case-control study.
Chun-Lai T; Murad S; Erlandsson MC; Hussein H; Sulaiman W; Dhaliwal JS; Bokarewa MI
Medicine (Baltimore); 2015 Jan; 94(4):e468. PubMed ID: 25634192
[TBL] [Abstract][Full Text] [Related]
25. Exposure to passive smoking and rheumatoid arthritis risk: results from the Swedish EIRA study.
Hedström AK; Klareskog L; Alfredsson L
Ann Rheum Dis; 2018 Jul; 77(7):970-972. PubMed ID: 29724731
[TBL] [Abstract][Full Text] [Related]
26. An investigation of the added value of an ACPA multiplex assay in an early rheumatoid arthritis setting.
van Heemst J; Trouw LA; Nogueira L; van Steenbergen HW; van der Helm-van Mil AH; Allaart CF; Serre G; Holmdahl R; Huizinga TW; Toes RE; van der Woude D
Arthritis Res Ther; 2015 Oct; 17():276. PubMed ID: 26437716
[TBL] [Abstract][Full Text] [Related]
27. Autoantibodies to citrullinated fibrinogen compared with anti-MCV and anti-CCP2 antibodies in diagnosing rheumatoid arthritis at an early stage: data from the French ESPOIR cohort.
Nicaise-Roland P; Nogueira L; Demattei C; de Chaisemartin L; Rincheval N; Cornillet M; Grootenboer-Mignot S; Dieudé P; Dougados M; Cantagrel A; Meyer O; Serre G; Chollet-Martin S
Ann Rheum Dis; 2013 Mar; 72(3):357-62. PubMed ID: 22580581
[TBL] [Abstract][Full Text] [Related]
28. Risk of progression from undifferentiated arthritis to rheumatoid arthritis: the effect of the PTPN22 1858T-allele in anti-citrullinated peptide antibody positive patients.
Feitsma AL; Toes RE; Begovich AB; Chokkalingam AP; de Vries RR; Huizinga TW; van der Helm-van Mil AH
Rheumatology (Oxford); 2007 Jul; 46(7):1092-5. PubMed ID: 17341507
[TBL] [Abstract][Full Text] [Related]
29. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
van der Woude D; Lie BA; Lundström E; Balsa A; Feitsma AL; Houwing-Duistermaat JJ; Verduijn W; Nordang GB; Alfredsson L; Klareskog L; Pascual-Salcedo D; Gonzalez-Gay MA; Lopez-Nevot MA; Valero F; Roep BO; Huizinga TW; Kvien TK; Martín J; Padyukov L; de Vries RR; Toes RE
Arthritis Rheum; 2010 May; 62(5):1236-45. PubMed ID: 20131291
[TBL] [Abstract][Full Text] [Related]
30. Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.
Thabet MM; Huizinga TW; Marques RB; Stoeken-Rijsbergen G; Bakker AM; Kurreeman FA; White SJ; Toes RE; van der Helm-van Mil AH
Ann Rheum Dis; 2009 Nov; 68(11):1775-80. PubMed ID: 19019892
[TBL] [Abstract][Full Text] [Related]
31. Strong combined gene-environment effects in anti-cyclic citrullinated peptide-positive rheumatoid arthritis: a nationwide case-control study in Denmark.
Pedersen M; Jacobsen S; Garred P; Madsen HO; Klarlund M; Svejgaard A; Pedersen BV; Wohlfahrt J; Frisch M
Arthritis Rheum; 2007 May; 56(5):1446-53. PubMed ID: 17469102
[TBL] [Abstract][Full Text] [Related]
32. Asthma and elevation of anti-citrullinated protein antibodies prior to the onset of rheumatoid arthritis.
Zaccardelli A; Liu X; Ford JA; Cui J; Lu B; Chu SH; Schur PH; Speyer CB; Costenbader KH; Robinson WH; Sokolove J; Karlson EW; Camargo CA; Sparks JA
Arthritis Res Ther; 2019 Nov; 21(1):246. PubMed ID: 31753003
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to porphyromonas gingivalis are associated with anticitrullinated protein antibodies in patients with rheumatoid arthritis and their relatives.
Hitchon CA; Chandad F; Ferucci ED; Willemze A; Ioan-Facsinay A; van der Woude D; Markland J; Robinson D; Elias B; Newkirk M; Toes RM; Huizinga TW; El-Gabalawy HS
J Rheumatol; 2010 Jun; 37(6):1105-12. PubMed ID: 20436074
[TBL] [Abstract][Full Text] [Related]
34. Quantification of the influence of cigarette smoking on rheumatoid arthritis: results from a population based case-control study, using incident cases.
Stolt P; Bengtsson C; Nordmark B; Lindblad S; Lundberg I; Klareskog L; Alfredsson L;
Ann Rheum Dis; 2003 Sep; 62(9):835-41. PubMed ID: 12922955
[TBL] [Abstract][Full Text] [Related]
35. A large-scale association study identified multiple HLA-DRB1 alleles associated with ACPA-negative rheumatoid arthritis in Japanese subjects.
Terao C; Ohmura K; Kochi Y; Ikari K; Maruya E; Katayama M; Shimada K; Murasawa A; Honjo S; Takasugi K; Matsuo K; Tajima K; Suzuki A; Yamamoto K; Momohara S; Yamanaka H; Yamada R; Saji H; Matsuda F; Mimori T
Ann Rheum Dis; 2011 Dec; 70(12):2134-9. PubMed ID: 21873689
[TBL] [Abstract][Full Text] [Related]
36. Missing Anticitrullinated Protein Antibody Does Not Affect Short-term Outcomes in Early Inflammatory Arthritis: From the Canadian Early Arthritis Cohort.
Shu J; Bykerk VP; Boire G; Haraoui B; Hitchon C; Thorne JC; Tin D; Keystone EC; Pope JE;
J Rheumatol; 2015 Nov; 42(11):2023-8. PubMed ID: 26329342
[TBL] [Abstract][Full Text] [Related]
37. Interplay between obesity and smoking with regard to RA risk.
Hedström AK; Klareskog L; Alfredsson L
RMD Open; 2019; 5(1):e000856. PubMed ID: 31168404
[TBL] [Abstract][Full Text] [Related]
38. Differences in the Spectrum of Anti-Citrullinated Protein Antibody Fine Specificities Between Malaysian and Swedish Patients With Rheumatoid Arthritis: Implications for Disease Pathogenesis.
Too CL; Murad S; Hansson M; Alm LM; Dhaliwal JS; Holmdahl R; Jakobsson PJ; Alfredsson L; Klareskog L; Rönnelid J; Padyukov L
Arthritis Rheumatol; 2017 Jan; 69(1):58-69. PubMed ID: 27483449
[TBL] [Abstract][Full Text] [Related]
39. The impact of genes on the occurrence of autoantibodies in rheumatoid arthritis. A study on disease discordant twin pairs.
Svendsen AJ; Hjelmborg JV; Kyvik KO; Houen G; Nielsen C; Skytthe A; Junker P
J Autoimmun; 2013 Mar; 41():120-5. PubMed ID: 23290888
[TBL] [Abstract][Full Text] [Related]
40. Palindromic rheumatism with positive anticitrullinated peptide/protein antibodies is not synonymous with rheumatoid arthritis. A longterm followup study.
Sanmartí R; Cabrera-Villalba S; Gómez-Puerta JA; Ruiz-Esquide V; Hernández MV; Salvador G; Ramirez J; Viñas O; Cañete JD
J Rheumatol; 2012 Oct; 39(10):1929-33. PubMed ID: 22859345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
